Nielsen and Wolters Kluwer Health form alliance

Share this article:

In an effort to raise the bar on consumer health targeting, messaging and measurement, Nielsen and Wolters Kluwer Health have launched HealthScape, an information platform.

The platform touts “de-identified patient prescription-related transaction data,” courtesy of Wolters Kluwer Health, combined with “consumer purchasing, attitudinal and behavior information,” from Nielsen, according to a company release. Specifically, Nielsen will offer its consumer OTC and consumer packaged goods data from its Homescan and Scantrack services. Wolters Kluwer Health will provide data from its SourceLx and Pharmaceutical Audit Suite (PHAST) services.

Media buyers, for example, can use HealthScape's prescription drug data to assess ad executions with greater precision, according to Rick Crangle, national director at Wolters Kluwer Health. The same metrics used to calibrate and execute media plans for consumer products can now be employed to bring more accuracy and sophistication to prescription drug media efforts. Key factors for determining [pharmaceutical] ad placement vary by product and market, but include managed care, physician recommendations, race, age and gender,” said Crangle.

Factors driving patient purchasing patterns, which are measurable by HealthScape, include co-morbidities, severity of condition, type of insurance plan and impact of co-pay versus retail price, managed care formulary controls and mass media advertising, and others, according to Crangle. 

HealthScape products are available in both subscription report format or as ad hoc reports, and can be customized based on a client's needs, noted Crangle.

Share this article:
You must be a registered member of MMM to post a comment.
close

Next Article in Channel

Email Newsletters

MM&M EBOOK: PATIENT ACCESS

Patient access to pharmaceuticals is a tale of two worlds—affordability has improved for the majority, while the minority is hampered by cost, distribution and red tape. To provide marketers with a well-rounded perspective, MM&M presents this e-book chock full of key insights. Click here to access it.

More in Channel

Five things for pharma marketers to know: Monday, September 15

Five things for pharma marketers to know: ...

Pharma has sought 76 meetings with FDA over biosimilars; Gilead licenses Sovaldi to India generic drugmakers; Pfizer and Ranbaxy Lipitor lawsuit dismissed.

Liraglutide, aiming for new indication, gets new name

Liraglutide, aiming for new indication, gets new name

Why Novo Nordisk is choosing not to leverage Victoza's brand equity as it seeks a weight-loss indication for liraglutide.

Five things for pharma marketers to know: Friday, September 12

Five things for pharma marketers to know: Friday, ...

An FDA panel voted in favor of liraglutide for weight loss; Allergan investors backing an attempted takeover of the firm crossed a critical threshold; and 100 million health wearables are ...